|
|
Profiling ER, PR, EGFR and HER2 in Breast Cancer Using Multiplex Tissue Immusta
|
2R44CA123994-02
|
$332,174
|
$332,174
|
JAMES, WILLIAM
|
20/20 GENESYSTEMS, INC.
|
|
|
SBIR PHASE I : ANTIBODY MICROARRAY FOR CANCER BIOMARKER DETECTION
|
N43CN700035-000
|
|
$0
|
ZHOU, XICHUN
|
ADA TECHNOLOGIES, INC.
|
|
|
SBIR Topic 252 - Nanopillar Platform for Improving Cancer Diagnosis
|
N43CO800061-000
|
$149,121
|
$59,648
|
ZHOU, XICHUN
|
ADA TECHNOLOGIES, INC.:1128750
|
|
|
Multiplex Gene Expression in Single Cells for Circulating Tumor Cell Detection
|
2R44CA122444-02A1
|
$539,326
|
$539,326
|
LUO, YULING
|
ADVANCED CELL DIAGNOSTICS, INC.
|
|
|
Real-Time Image and Dose Guided Radiation Therapy System
|
1R43CA130494-01A1
|
$149,964
|
$149,964
|
SIOSHANSI, PIRAN
|
ADVANCED RADIATION THERAPY, LLC
|
|
|
SBIR PHASE I: ANTIBODY ARRAY FOR CANCER DETECTION
|
N43CN700065-000
|
|
$0
|
BOCHKARIOV, DMITRY
|
ADVANSTA INC
|
|
|
High Resolution Digital Imaging X-ray Detectors
|
5R42CA110192-05
|
$311,601
|
$311,601
|
Lee, Michael
|
AGUILA TECHNOLOGIES, INC.
|
|
|
Add-on module for ONCAD for diagnosing infiltrating lobular carcinoma
|
1R43CA132259-01A1
|
$100,058
|
$100,058
|
PENN, ALAN
|
ALAN PENN AND ASSOCIATES, INC.
|
|
|
Regulation of Fibronectin Matrix Assembly by uPAR
|
2R01CA058626-15A2
|
$269,742
|
$134,871
|
MC KEOWN-LONGO, PAULA
|
ALBANY MEDICAL COLLEGE
|
|
|
An Exploration of the Determinants that Impact Breast and Cervical Cancer Control
|
5R03CA132550-02
|
$50,000
|
$25,000
|
English, Kevin
|
ALBUQUERQUE AREA INDIAN HEALTH BOARD
|
|
|
Computer-aided tool for diagnostic breast ultrasound
|
5R44CA112858-03
|
$443,533
|
$443,533
|
Galperin, Michael
|
ALMEN LABORATORIES, INC.
|
|
|
Molecular Test for Inherited Mutations in Breast Cancer
|
5R44CA110403-04
|
$463,209
|
$463,209
|
Lim, Mark
|
AMBERGEN, INC
|
|
|
Characterizing Genetic Susceptibility to Breast and Prostate Cancer: The BPC3.
|
2U01CA098710-05
|
$1,063,219
|
$531,610
|
THUN, MICHAEL
|
AMERICAN CANCER SOCIETY, INC.
|
|
|
American College of Radiology Imaging Network
|
2U01CA080098-10
|
$9,101,961
|
$1,137,745
|
Schnall, Mitchell
|
AMERICAN COLLEGE OF RADIOLOGY
|
|
|
QUALITY RESEARCH IN RADIATION ONCOLOGY: ACR PCS
|
5R01CA065435-10
|
$740,839
|
$148,168
|
WILSON, JESSE
|
AMERICAN COLLEGE OF RADIOLOGY
|
|
|
Human Apyrase to Disrupt Cancer Therapy
|
1R43CA130192-01A2
|
$196,745
|
$196,745
|
CHEN, RIDONG
|
APT THERAPEUTICS, INC.
|
|
|
An Exploration of Perceived Racial/Ethnic Discrimination in Cancer Care Delivery
|
5R03CA124752-02
|
$77,999
|
$77,999
|
Campesino, Maureen
|
ARIZONA STATE UNIVERSITY-TEMPE CAMPUS
|
|
|
Inhibitors of p90Rsk
|
7R01CA116566-03
|
$79,822
|
$79,822
|
Hecht, Sidney
|
ARIZONA STATE UNIVERSITY-TEMPE CAMPUS
|
|
|
Molecular Target Focused Discovery of Anticancer Drugs
|
2R01CA090441-06A2
|
$381,250
|
$53,375
|
PETTIT, GEORGE
|
ARIZONA STATE UNIVERSITY-TEMPE CAMPUS
|
|
|
Drug Delivery Carriers Targeted to Breast Tumor by Fusion Phage Proteins
|
5R01CA125063-02
|
$373,539
|
$373,539
|
PETRENKO, VALERY
|
AUBURN UNIVERSITY AT AUBURN
|
|
|
High-Throughput Evaluation of Breast Cancer Markers
|
3U01CA117378-04S1
|
$215,538
|
$215,538
|
ZANGAR, RICHARD
|
BATTELLE PACIFIC NORTHWEST LABORATORIES
|
|
|
High-Throughput Evaluation of Breast Cancer Markers
|
5U01CA117378-04
|
$390,528
|
$390,528
|
ZANGAR, RICHARD
|
BATTELLE PACIFIC NORTHWEST LABORATORIES
|
|
|
Bay Area Tumor Institute CCOP
|
5U10CA045461-19
|
$481,201
|
$163,608
|
Feusner, James
|
BAY AREA TUMOR INSTITUTE
|
|
|
Role of Cancer Stem Cells in Malignant Progression of Ductal Carcinoma in Situ.
|
5K99CA127462-02
|
$17,010
|
$17,010
|
BEHBOD, FARIBA
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Molecular Mechanisms by which Rexinoids Prevent Breast Cancer
|
5R01CA078480-11
|
$341,085
|
$341,085
|
BROWN, POWEL
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Targeting AP-1 / ER Crosstalk for the Prevention and Treatment of Breast Cancer
|
5R01CA123246-02
|
$285,000
|
$285,000
|
BROWN, POWEL
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Targeting Notch, PI3K-AKT and other novel pathways in breast cancer stem cells
|
1R01CA138197-01
|
$475,325
|
$475,325
|
CHANG, JENNY
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
REGULATION OF GENETIC STABILITY BY THE INT6 FAMILY
|
5R01CA090464-06
|
$272,340
|
$272,340
|
CHANG, ERIC
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Selective control of multiple Ras signaling activities
|
5R01CA107187-04
|
$235,955
|
$58,989
|
CHANG, ERIC
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Breast cancer response markers to a dual HER1/2 blocker
|
5R01CA112305-04
|
$252,236
|
$252,236
|
CHANG, JENNY
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
NSABP Participating Sites
|
5U10CA118735-03
|
$66,231
|
$58,283
|
CHANG, JENNY
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Tumor Suppressor Function of Smad4 by Ubiquitin
|
5R01CA108454-05
|
$224,756
|
$112,378
|
FENG, XIN-HUA
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
A Hypersensitive ER alpha Mutant in Breast Cancer Hormone Resistance
|
2R01CA072038-11A1
|
$300,198
|
$300,198
|
FUQUA, SUZANNE
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Translational Breast Cancer Research Training Program
|
2T32CA090221-06A1
|
$270,534
|
$270,534
|
FUQUA, SUZANNE
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Molecular Dissection of Tumor Invasion
|
5R01CA087751-07
|
$246,598
|
$123,299
|
GOODE, SCOTT
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Regulation of Mammary Stem Cells
|
1R01CA127857-01A1
|
$318,513
|
$318,513
|
LEWIS, MICHAEL
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
PROGENITOR CELLS AND ONCOGENE TARGETS IN BREAST CANCER
|
5R01CA113869-04
|
$280,899
|
$280,899
|
LI, YI
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
PROGESTERONE RECEPTOR IN BREAST DEVELOPMENT AND CANCER
|
5R01CA077530-09
|
$302,232
|
$302,232
|
LYDON, JOHN
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
High Content Analysis to Identify Biomarkers for Chemopreventive Drug Activity
|
1R03CA137777-01
|
$76,750
|
$76,750
|
MANCINI, MICHAEL
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Multiplexed Methods for the Study of Chromosomal Aberrations in Cancer
|
5R33CA114151-02
|
$229,170
|
$229,170
|
MILOSAVLJEVIC, ALEKSANDAR
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Novel Gene Networks in Breast Development and Cancer
|
5P01CA030195-26
|
$2,398,875
|
$2,398,875
|
Oesterreich, Steffi
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Translational Research in Breast Cancer
|
2P50CA058183-14
|
$2,300,000
|
$2,300,000
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-02S1
|
$117,286
|
$48,087
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Baylor College of Medicine Cancer Center
|
5P30CA125123-02
|
$1,515,000
|
$621,150
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Molecular Basis of Aneuploidy
|
5R01CA109330-03
|
$232,676
|
$232,676
|
PATI, DEBANANDA
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Function Analysis of BRCA1 BRCT Domains in Breast Cancer
|
5F31CA119928-03
|
$18,164
|
$18,164
|
Rodriguez, Maria
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Mouse Models of Human Breast Cancer
|
3U01CA084243-10S1
|
$43,919
|
$43,919
|
Rosen, Jeffrey
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Hormonal Regulation of Breast Cancer
|
5R37CA016303-33
|
$763,328
|
$763,328
|
Rosen, Jeffrey
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Mouse Models of Human Breast Cancer
|
5U01CA084243-10
|
$831,781
|
$831,781
|
Rosen, Jeffrey
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Diagnostic Cancer Imaging using NIR Fluorescent Agents and FDPM
|
3R01CA112679-13S1
|
$50,006
|
$50,006
|
SEVICK-MURACA, EVA
|
BAYLOR COLLEGE OF MEDICINE
|
|
Total relevant funding to Breast Cancer for this search: $572,597,443
|
